YS Biopharma /
Summit
YS Biopharma to combine with Summit Healthcare Acquisition Corp.
- Terms
- Not stated
- Stage
- Agreement signed
What happened
YS Biopharma Co., Ltd and Summit Healthcare Acquisition Corp. entered into a Business Combination Agreement on September 29, 2022. Summit will become a wholly-owned subsidiary of YS Biopharma, and the combined company will become public.
The filing does not disclose a transaction value.
The source
Everything on this page comes from the source below.
YS Biopharma to combine with Summit Healthcare Acquisition Corp.
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly